Department of Neurology, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Eur J Neurol. 2022 Mar;29(3):782-789. doi: 10.1111/ene.15182. Epub 2021 Dec 9.
Tumefactive demyelination (TD) presents with large inflammatory lesions mimicking tumors or other space-occupying lesions. Limited epidemiological, clinical and radiological data exist for TD. We aimed to report the incidence rate, and clinical and radiological features of TD in Olmsted County, Minnesota.
We retrospectively reviewed patients with central nervous system inflammatory demyelination-related diagnostic codes (January 1, 1998 to December 31, 2018) in the Rochester Epidemiology Project database, and adjusted incidence rates by age and sex to the 2010 US total population. We used the Expanded Disability Status Scale (EDSS) to assess outcomes (index attack and last follow-up).
Of 792 multiple sclerosis (MS) patients, 15 (eight males, seven females) had tumefactive MS, representing 1.9% of the MS population. The median (range) age at attack onset was 34.2 (2-61) years. Tumefactive lesion was the first clinical MS attack in 8/16 patients. Cerebrospinal fluid oligoclonal bands (OCBs) were present in 8/12 patients and 11/16 patients met the Barkhof criteria for dissemination in space. Most patients remained fully ambulatory (EDSS score ≤4 in 13/16 patients [81%]) after a median (range) follow-up duration of 10.5 (1-20.5) years. Age-adjusted annual incidence rates were 0.46/100,000 (95% confidence interval [CI] 0.12-0.81) for female patients, 0.66/100,000 (95% CI 0.23-1.02) for male patients, and 0.56/100,000 [95% CI 0.28-0.83] overall. When age- and sex-adjusted to the 2010 US total population, the overall annual incidence rate was 0.57 (95% CI 0.28-0.84). Despite aggressive clinical presentation at disease onset, most patients remained fully ambulatory (EDSS score ≤4 in 13/16 patients) with a relapsing-remitting course.
Although incidence is rare, TD should be suspected in patients presenting with subacutely progressive neurological deficits associated with magnetic resonance imaging findings of ring enhancement, apparent diffusion coefficient restriction, and OCB on spinal fluid analysis.
肿块样脱髓鞘病变(TD)表现为大的炎症性病变,类似于肿瘤或其他占位性病变。目前,TD 的流行病学、临床和影像学数据有限。本研究旨在报告明尼苏达州奥姆斯特德县(Olmsted County,Minnesota)TD 的发病率,以及其临床和影像学特征。
我们对罗切斯特流行病学项目数据库中与中枢神经系统炎症性脱髓鞘相关的诊断代码(1998 年 1 月 1 日至 2018 年 12 月 31 日)进行了回顾性分析,并根据年龄和性别将发病率调整至 2010 年美国总人口。我们使用扩展残疾状况量表(EDSS)评估结局(首发发作和末次随访)。
在 792 例多发性硬化症(MS)患者中,15 例(8 例男性,7 例女性)存在肿块样 MS,占 MS 患者的 1.9%。发病时的中位(范围)年龄为 34.2(2-61)岁。16 例患者中有 8 例(50%)的首发临床症状为肿块样病变。12 例患者的脑脊液寡克隆带(OCB)阳性,11 例患者符合 Barkhof 标准的空间播散。中位(范围)随访时间为 10.5(1-20.5)年后,大多数患者仍完全能行走(16 例患者中有 13 例[81%]的 EDSS 评分≤4)。女性患者的年龄校正后年发病率为 0.46/100,000(95%置信区间 [CI]:0.12-0.81),男性患者为 0.66/100,000(95% CI:0.23-1.02),总体为 0.56/100,000(95% CI:0.28-0.83)。当按年龄和性别调整至 2010 年美国总人口时,总年发病率为 0.57(95% CI:0.28-0.84)。尽管首发时的临床表现较为严重,但大多数患者仍保持完全行走能力(16 例患者中有 13 例[81%]的 EDSS 评分≤4),疾病呈复发缓解型病程。
尽管发病率较低,但对于磁共振成像表现为环形增强、表观弥散系数受限和脑脊液 OCB 的亚急性进展性神经功能缺损患者,应考虑诊断为 TD。